VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
218 hedge funds and large institutions have $1.32B invested in Meridian Bioscience Inc in 2022 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 67 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.29B → $1.32B (+$25.8M)
0% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 67
Holders
218
Holding in Top 10
7
Calls
$7.31M
Puts
$2.21M
Top Buyers
| 1 | +$64.4M | |
| 2 | +$17.8M | |
| 3 | +$10.9M | |
| 4 |
E
Ergoteles
New York
|
+$9.95M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$9.95M |
Top Sellers
| 1 | -$90.9M | |
| 2 | -$19.2M | |
| 3 | -$8.84M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.39M |
| 5 |
DAM
DLD Asset Management
New York
|
-$7.88M |